TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification February 5, 1999
TCL Archive President’s FY 1991 Budget Provides NCI 3.9% Increase, But Grant Budgets To Be Cut 20% February 2, 1990